SYSTEM AND METHOD FOR GENERATING CLINICAL TRIAL PROTOCOL DESIGN DOCUMENT WITH SELECTION OF PATIENT AND INVESTIGATOR
Patent №
US 11,521,713
Granted
2022-12-06
Filed 2019
Owner
HCL TECHNOLOGIES LIMITED
Lab
—
AI components
6
ml · nlp · vision · kr · planning · hardware
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16414618
Disclosed is a system for generating Clinical trial protocol design document with selection of a Patient and an Investigator for a clinical trial process. The system inputs meaningful information derived from the raw data, a pre-Drafted protocol, a regulatory authorities' protocol curated by regulatory authorities, and a pre-stored dataset, present in a repository. A Clinical trial protocol design document is drafted by generating a case frame upon extracting data in form of a key value into a standard document. Each key value is validated and a prediction score is computed based on overlapping of the interim Clinical trial protocol design template with the pre-Drafted protocol and the regulatory authorities' protocol to determine whether the interim Clinical trial protocol design document is approved or rejected. A Clinical trial protocol design document is generated when the interim Clinical trial protocol design document is approved.
AI classification
Ownership
HCL TECHNOLOGIES LIMITED
assignment · 500230300
Assignors
SABHARWAL, NAVIN, AGRAWAL, AMIT
On an employer assignment, the assignors are typically the inventors.